bf/NASDAQ:NVNO_icon.png

NASDAQ:NVNO

enVVeno Medical Corporation

  • Stock

USD

Last Close

0.66

06/11 21:56

Market Cap

77.85M

Beta: 1.25

Volume Today

108.72K

Avg: 25.60K

PE Ratio

−2.05

PFCF: −3.12

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
45.45K
-
45.45K
0%
average payables
580.12K
-
996.60K
71.79%
1.26M
26.85%
1.15M
9.10%
1.31M
13.63%
975.22K
25.31%
604.04K
38.06%
324K
46.36%
average receivables
94.88K
-
112.47K
18.54%
33.60K
70.12%
16.01K
52.35%
book value per share
-8.15
-
-9.62
17.96%
-28.71
198.51%
5.44
118.94%
1.57
71.12%
5.50
250.00%
6.27
14.04%
3.45
44.98%
3.76
8.90%
capex per share
-0.01
-
-0.85
14,160.15%
-0.03
96.69%
-0.03
17.57%
-0.58
1,640.21%
-0.14
75.81%
-0.04
69.64%
-0.01
75.84%
-0.00
73.80%
capex to depreciation
-0.02
-
-2.47
11,731.08%
-0.08
96.82%
-0.09
18.50%
-0.92
885.31%
-0.47
48.82%
-0.81
72.99%
-0.22
73.03%
-0.06
72.41%
capex to operating cash flow
0.00
-
0.12
9,235.84%
0.00
97.85%
0.00
24.91%
0.06
3,057.66%
0.02
61.95%
0.03
32.25%
0.01
76.29%
0.00
76.23%
capex to revenue
-0.48
-
-0.03
94.55%
-0.07
156.97%
-11.65
17,391.50%
cash per share
3.61
-
0.13
96.43%
0.20
55.56%
7.32
3,552.04%
2.07
71.67%
7.23
248.57%
6.31
12.77%
3.48
44.86%
3.77
8.52%
days of inventory on hand
40.95
-
days payables outstanding
244.13
-
1.26K
417.04%
days sales outstanding
88.13
-
30.42
65.48%
62.65
105.95%
debt to assets
0.64
-
0.35
44.27%
1.18
233.15%
0.01
99.36%
0.25
3,190.24%
0.08
66.50%
0.03
58.40%
0.04
18.48%
0.03
30.01%
debt to equity
-0.51
-
-0.15
70.70%
-0.24
56.89%
0.01
105.63%
0.87
6,430.34%
0.12
85.66%
0.04
70.28%
0.04
20.17%
0.03
31.51%
dividend yield
earnings yield
-0.03
-
-0.06
111.19%
-0.15
160.28%
-0.94
515.55%
-0.88
6.85%
-0.80
9.23%
-0.28
64.54%
-0.42
49.87%
-0.37
12.35%
enterprise value
57.72M
-
58.05M
0.57%
53.33M
8.13%
11.07M
79.24%
8.22M
25.77%
2.72M
66.93%
4.48M
64.85%
54.43M
1,115.20%
61.01M
12.08%
enterprise value over ebitda
-49.57
-
-12.88
74.02%
-6.95
46.03%
-1.50
78.48%
-1.24
17.26%
-0.30
75.50%
-0.27
11.80%
-2.22
730.61%
-2.42
8.84%
ev to operating cash flow
-28.58
-
-18.82
34.16%
-12.69
32.56%
-1.74
86.27%
-1.39
19.99%
-0.35
74.60%
-0.38
6.84%
-3.49
821.64%
-3.24
7.17%
ev to sales
73.86
-
126.34
71.05%
59.34
53.03%
263.02
343.21%
free cash flow per share
-4.61
-
-7.88
71.03%
-10.87
37.86%
-17.00
56.48%
-9.93
41.60%
-6.08
38.73%
-1.41
76.87%
-1.40
0.43%
-1.54
9.61%
free cash flow yield
-0.04
-
-0.06
71.03%
-0.08
37.86%
-0.46
455.81%
-0.72
56.63%
-0.70
2.61%
-0.21
69.64%
-0.27
28.66%
-0.30
8.76%
graham net net
-11.09
-
-13.12
18.32%
-34.15
160.23%
3.32
109.71%
-1.80
154.40%
4.56
353.06%
5.93
29.82%
3.22
45.73%
3.58
11.18%
graham number
25.90
-
40.88
57.84%
113.94
178.74%
65.28
42.71%
20.67
68.33%
29.22
41.37%
16.22
44.49%
12.96
20.11%
12.71
1.92%
income quality
1.26
-
0.91
27.67%
0.54
40.77%
0.49
9.65%
0.77
58.68%
0.84
8.68%
0.72
14.71%
0.63
11.66%
0.80
26.66%
intangibles to total assets
0.31
-
0.69
121.00%
0.50
27.56%
0.19
62.62%
0
100%
0
0
0
0
interest coverage
-14.57
-
-80.48
452.37%
-29.13
63.80%
-1.14
96.07%
153.77
13,531.10%
2.44K
1,488.89%
902.91
63.04%
94.80
89.50%
interest debt per share
4.38
-
1.57
64.02%
7.30
363.42%
18.39
152.11%
1.28
93.04%
0.68
46.94%
0.23
66.28%
0.13
43.49%
0.11
11.91%
inventory turnover
8.91
-
invested capital
-0.51
-
-0.15
70.70%
-0.24
56.89%
0.01
105.63%
0.87
6,430.34%
0.12
85.66%
0.04
70.28%
0.04
20.17%
0.03
31.51%
market cap
57.47M
-
57.47M
0%
50.79M
11.63%
13.81M
72.81%
8.67M
37.24%
11.17M
28.88%
57.20M
412.04%
57.27M
0.13%
63.23M
10.40%
net current asset value
-4.67M
-
-5.61M
20.18%
-13.17M
134.89%
1.31M
109.97%
-1.02M
177.66%
6.13M
700.66%
51.75M
744.26%
36.50M
29.45%
44.49M
21.87%
net debt to ebitda
-0.21
-
-0.13
39.42%
-0.33
159.04%
0.37
211.82%
0.07
81.67%
0.94
1,289.89%
3.15
233.66%
0.12
96.32%
0.09
24.13%
net income per share
-3.66
-
-7.72
111.19%
-20.10
160.28%
-34.83
73.29%
-12.10
65.27%
-6.91
42.90%
-1.87
72.98%
-2.16
15.98%
-1.91
11.67%
operating cash flow per share
-4.60
-
-7.03
52.75%
-10.84
54.16%
-16.97
56.58%
-9.35
44.89%
-5.94
36.44%
-1.36
77.04%
-1.39
1.91%
-1.53
10.23%
payables turnover
1.50
-
0.29
80.66%
receivables turnover
4.14
-
12.00
189.69%
5.83
51.45%
research and ddevelopement to revenue
1.54
-
6.64
331.39%
70.61
963.39%
return on tangible assets
-0.81
-
-6.16
658.30%
-7.05
14.46%
-4.51
36.03%
-2.22
50.75%
-0.85
61.88%
-0.28
66.84%
-0.58
107.83%
-0.48
17.12%
revenue per share
1.79
-
1.09
39.22%
0.50
54.25%
0.05
90.05%
roe
0.45
-
0.80
79.03%
0.70
12.81%
-6.40
1,014.93%
-7.70
20.27%
-1.26
83.69%
-0.30
76.31%
-0.63
110.79%
-0.51
18.89%
roic
0.91
-
0.80
11.72%
0.74
8.06%
-4.29
683.29%
-2.84
33.89%
-1.04
63.24%
-0.28
72.85%
-0.58
105.59%
-0.52
11.60%
sales general and administrative to revenue
shareholders equity per share
-8.15
-
-9.62
17.96%
-28.71
198.51%
5.44
118.94%
1.57
71.12%
5.50
250.00%
6.27
14.04%
3.45
44.98%
3.76
8.90%
stock based compensation to revenue
1.92
-
2.08
8.29%
10.31
395.21%
30.15
192.57%
tangible asset value
-4.48M
-
-5.45M
21.80%
-12.24M
124.50%
1.37M
111.19%
989.94K
27.74%
7.10M
617.00%
54.40M
666.49%
38.73M
28.81%
46.20M
19.29%
tangible book value per share
-10.20
-
-12.43
21.80%
-31.57
154.05%
3.66
111.59%
1.57
57.07%
5.50
250.00%
6.27
14.04%
3.45
44.98%
3.76
8.90%
working capital
-2.87M
-
-1.67M
41.71%
-8.00M
378.33%
1.31M
116.42%
-452.43K
134.43%
6.38M
1,510.77%
53.46M
737.56%
37.91M
29.09%
45.55M
20.17%

All numbers in USD (except ratios and percentages)